A Study of The Impact of Severe Hepatic Impairment on the Pharmacokinetics and Safety of Vemurafenib in BRAF V600 Mutation-Positive Cancer Participants
Clinical trial NCT01767623 · COMPLETED
Trial details
- NCT number
- NCT01767623
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-20
- Primary completion
- 2017-04-20
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.